Divi's Lab.

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,818.50",
    "chg": 57.4,
    "chgp": "0.85%",
    "dir": 1,
    "prev_price": "6,761.10",
    "mcapval": "177,827.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "May 18",
    "curr_time": "",
    "bse_nse_vol": "3.51 lacs",
    "exc_status": "Active",
    "traded_date": "May 18, 2026",
    "traded_date_str": "2026 05 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Gains 0.78%: 3 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-078-3-key-factors-driving-the-weeks-mixed-momentum-3994792",
        "imagepath": "",
        "date": "2026-05-16 17:09:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>11 May:</strong> Stock opens at Rs.6,714.25 with minor gain despite Sensex fall</p>\n                    <p><strong>12 May:</strong> Downgrade to Sell rating announced amid mixed financial and technical signals</p>\n                    <p><strong>14 May:</strong> Technical momentum shifts from mildly bearish to sideways with bullish short-term indicators</p>\n                    <p><strong>15 May:</strong> Week closes at Rs.6,761.10, up 0.78% for the week versus Sensex decline</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,708.90</div></div>\n            ..."
      },
      {
        "title": "When is the next results date for Divis Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-divis-laboratories-ltd-3993486",
        "imagepath": "",
        "date": "2026-05-15 23:16:52",
        "description": "The next results date for Divis Laboratories Ltd is scheduled for 23 May 2026...."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3990408",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_technicaldot_3990408.png",
        "date": "2026-05-14 08:02:07",
        "description": "Divis Laboratories Ltd has exhibited a notable shift in price momentum, transitioning from a mildly bearish technical trend to a sideways stance, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 2.24% daily gain to ₹6,792.20, coupled with mixed readings from MACD, RSI, and moving averages, suggests a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Divis Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3986789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_mojoScore_3986789.png",
        "date": "2026-05-12 08:17:09",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 11 May 2026. This revision reflects a combination of deteriorating technical indicators, expensive valuation metrics, and subdued long-term financial growth despite strong recent earnings and market outperformance."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3986436",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_technicaldot_3986436.png",
        "date": "2026-05-12 08:03:37",
        "description": "Divis Laboratories Ltd has experienced a subtle but notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite this, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment for this large-cap pharmaceutical player."
      },
      {
        "title": "Divis Laboratories Gains 1.37%: Technical Stabilisation and Financial Strength Drive Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-137-technical-stabilisation-and-financial-strength-drive-week-3983608",
        "imagepath": "",
        "date": "2026-05-09 17:06:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.6,618.20</p>\n                    <p><strong>5 May:</strong> Mojo Grade upgraded to Hold by MarketsMOJO</p>\n                    <p><strong>6 May:</strong> Stock gains 0.80% amid strong Sensex rally</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.6,708.90 (+1.37%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,618.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.6,708.90</div><div class=\"stat-change positive\">+1.37%</div></di..."
      },
      {
        "title": "Divis Laboratories Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-upgraded-to-hold-by-marketsmojo-on-technical-and-financial-improvements-3975166",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_mojoScore_3975166.png",
        "date": "2026-05-05 08:17:33",
        "description": "Divis Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook alongside steady financial performance. The upgrade, effective from 4 May 2026, is driven by a combination of enhanced technical indicators, stable quality metrics, valuation considerations, and positive financial trends, positioning the stock as a cautious but promising pick within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Signal Stabilisation Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-signal-stabilisation-amid-mixed-indicators-3974767",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_technicaldot_3974767.png",
        "date": "2026-05-05 08:03:01",
        "description": "Divis Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more neutral sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a stabilising outlook for the large-cap pharmaceutical player amid broader market fluctuations."
      },
      {
        "title": "Divis Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-sell-3972039",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_mojoScore_3972039.png",
        "date": "2026-05-01 10:10:42",
        "description": "Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date perspective on its performance and outlook."
      }
    ],
    "total": 626,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "15-May-2026",
      "details": "Intimation of schedule of earnings conference call for the quarter and year ended March 31 2026 to be held on May 23 2026 at 14:30 Hrs (IST).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-May-2026",
      "details": "Copy of Newspaper Publication regarding loss of Share Certificate.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering And Approving Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2026 And To Recommend Dividend If Any For The Financial Year 2025-26.",
      "datetime": "14-May-2026",
      "details": "Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 inter alia to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31 2026 and to recommend dividend if any for the financial year 2025-26.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "23 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Gains 0.78%: 3 Key Factors Driving the Week’s Mixed Momentum

2026-05-16 17:09:03

Key Events This Week

11 May: Stock opens at Rs.6,714.25 with minor gain despite Sensex fall

12 May: Downgrade to Sell rating announced amid mixed financial and technical signals

14 May: Technical momentum shifts from mildly bearish to sideways with bullish short-term indicators

15 May: Week closes at Rs.6,761.10, up 0.78% for the week versus Sensex decline

Week Open

Rs.6,708.90

...

Read full news article

When is the next results date for Divis Laboratories Ltd?

2026-05-15 23:16:52

The next results date for Divis Laboratories Ltd is scheduled for 23 May 2026....

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-14 08:02:07

Divis Laboratories Ltd has exhibited a notable shift in price momentum, transitioning from a mildly bearish technical trend to a sideways stance, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 2.24% daily gain to ₹6,792.20, coupled with mixed readings from MACD, RSI, and moving averages, suggests a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Divis Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-05-12 08:17:09

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 11 May 2026. This revision reflects a combination of deteriorating technical indicators, expensive valuation metrics, and subdued long-term financial growth despite strong recent earnings and market outperformance.

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-12 08:03:37

Divis Laboratories Ltd has experienced a subtle but notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite this, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment for this large-cap pharmaceutical player.

Read full news article

Divis Laboratories Gains 1.37%: Technical Stabilisation and Financial Strength Drive Week

2026-05-09 17:06:16

Key Events This Week

4 May: Week opens at Rs.6,618.20

5 May: Mojo Grade upgraded to Hold by MarketsMOJO

6 May: Stock gains 0.80% amid strong Sensex rally

8 May: Week closes at Rs.6,708.90 (+1.37%)

Week Open

Rs.6,618.20

Week Close

Rs.6,708.90

+1.37%

Read full news article

Divis Laboratories Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Improvements

2026-05-05 08:17:33

Divis Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook alongside steady financial performance. The upgrade, effective from 4 May 2026, is driven by a combination of enhanced technical indicators, stable quality metrics, valuation considerations, and positive financial trends, positioning the stock as a cautious but promising pick within the Pharmaceuticals & Biotechnology sector.

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Signal Stabilisation Amid Mixed Indicators

2026-05-05 08:03:01

Divis Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more neutral sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a stabilising outlook for the large-cap pharmaceutical player amid broader market fluctuations.

Read full news article

Divis Laboratories Ltd is Rated Sell

2026-05-01 10:10:42

Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

View All News